Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Authors
Keywords
Interleukin-6 (IL-6), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Inflammation, Pneumonia, Cytokine storm, Cancer, C-reactive protein (CRP), Hypoxia, Tocilizumab
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 145, Issue -, Pages 112419
Publisher
Elsevier BV
Online
2021-11-12
DOI
10.1016/j.biopha.2021.112419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study
- (2021) GIANLUCA VANNI et al. ANTICANCER RESEARCH
- Steps in metastasis: an updated review
- (2021) Jamal Majidpoor et al. MEDICAL ONCOLOGY
- Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
- (2021) Julie Gorham et al. PLoS One
- Multifactorial expression of IL‑6 with update on COVID‑19 and the therapeutic strategies of its blockade (Review)
- (2021) Elena Niculet et al. Experimental and Therapeutic Medicine
- Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis
- (2021) Qi Han et al. Frontiers in Pharmacology
- Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA
- (2021) Pasquale Paolisso et al. Cardiovascular Diabetology
- CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients
- (2021) M. Hernandez-Cedeño et al. CELL STRESS & CHAPERONES
- Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients
- (2021) Penghui Yang et al. Cellular & Molecular Immunology
- The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19
- (2021) Boyi Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Immunoregulatory therapy strategies that target cytokine storms in patients with COVID‑19 (Review)
- (2021) Xianyao Wang et al. Experimental and Therapeutic Medicine
- Efficacy and tolerability of bevacizumab in patients with severe Covid-19
- (2021) Jiaojiao Pang et al. Nature Communications
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
- (2021) Arvinder S Soin et al. Lancet Respiratory Medicine
- Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
- (2021) André Santa Cruz et al. Frontiers in Immunology
- Role of Interleukin-6 in Vascular Health and Disease
- (2021) Paulina Villar-Fincheira et al. Frontiers in Molecular Biosciences
- Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak
- (2021) P. Sabaka et al. BMC INFECTIOUS DISEASES
- Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
- (2021) Nunzia D’Onofrio et al. Cardiovascular Diabetology
- The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives
- (2021) Jamal Majidpoor et al. CLINICAL IMMUNOLOGY
- Organ tropism in solid tumor metastasis: an updated review
- (2021) Keywan Mortezaee Future Oncology
- SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
- (2021) Parisa Shiri Aghbash et al. LIFE SCIENCES
- Mechanisms of thrombosis and cardiovascular complications in COVID-19
- (2021) Eden M. Page et al. THROMBOSIS RESEARCH
- Angiogenesis as a hallmark of solid tumors - clinical perspectives
- (2021) Jamal Majidpoor et al. CELLULAR ONCOLOGY
- Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
- (2021) Francesca Coperchini et al. Frontiers in Immunology
- IL-6 modulation for COVID-19: the right patients at the right time?
- (2021) Paolo Antonio Ascierto et al. Journal for ImmunoTherapy of Cancer
- Decreased T Cell Levels in Critically Ill Coronavirus Patients: Single-Center, Prospective and Observational Study
- (2021) Jingjing Xu et al. Journal of Inflammation Research
- Role of interleukins in the pathogenesis of pulmonary fibrosis
- (2021) Yi Xin She et al. Cell Death Discovery
- Normalization in tumor ecosystem: Opportunities and challenges
- (2021) Keywan Mortezaee CELL BIOLOGY INTERNATIONAL
- Interleukin-2 therapy of cancer-clinical perspectives
- (2021) Jamal Majidpoor et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The current knowledge concerning solid cancer and therapy
- (2021) Masoud Najafi et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives
- (2021) Keywan Mortezaee LIFE SCIENCES
- SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells
- (2021) Jae Hyung Jung et al. Nature Communications
- Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews
- (2021) Jamie Hartmann-Boyce et al. DIABETES CARE
- The impact of hypoxia on immune state in cancer
- (2021) Keywan Mortezaee et al. LIFE SCIENCES
- Signals of Th2 immune response from COVID-19 patients requiring intensive care
- (2020) Luca Roncati et al. ANNALS OF HEMATOLOGY
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
- (2020) Tomasz J Guzik et al. CARDIOVASCULAR RESEARCH
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
- (2020) R. Marfella et al. DIABETES & METABOLISM
- Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
- (2020) Celestino Sardu et al. DIABETES CARE
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection
- (2020) Jihye Kim et al. INTERNATIONAL JOURNAL OF OBESITY
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer
- (2020) Ina Bähr et al. Frontiers in Immunology
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
- (2020) Yingxia Liu et al. National Science Review
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
- (2020) Oliver J. Pickles et al. BRITISH JOURNAL OF CANCER
- Systemic inflammation as fuel for acute liver injury in COVID-19
- (2020) Maria Effenberger et al. DIGESTIVE AND LIVER DISEASE
- Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery
- (2020) Charalampos Lazaridis et al. Hellenic Journal of Cardiology
- Early administration of Interleukin-6 inhibitors for patients with severe Covid-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
- (2020) Pranay Sinha et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in‐hospital mortality
- (2020) Lei Zhang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Covid-19 and the cardiovascular system: a comprehensive review
- (2020) Rafael Bellotti Azevedo et al. JOURNAL OF HUMAN HYPERTENSION
- Obesity is Associated with More Critical Illness in COVID-19
- (2020) Abhishek Sharma et al. MAYO CLINIC PROCEEDINGS
- Focus shifts to antibody cocktails for COVID-19 cytokine storm
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
- (2020) Pasquale Paolisso et al. Frontiers in Pharmacology
- When Innate Immunity Meets Angiogenesis—The Role of Toll-Like Receptors in Endothelial Cells and Pulmonary Hypertension
- (2020) Aneel Bhagwani et al. Frontiers in Medicine
- Unique immunological profile in patients with COVID-19
- (2020) Stefania Varchetta et al. Cellular & Molecular Immunology
- COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department
- (2020) Mathias Van Singer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
- (2020) José María Galván-Román et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
- (2020) Francesco Perrone et al. Journal of Translational Medicine
- Immune escape: A critical hallmark in solid tumors
- (2020) Keywan Mortezaee LIFE SCIENCES
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: Why are age and obesity risk factors for serious disease?
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Acute kidney injury in patients with SARS-CoV-2 infection
- (2020) Adrien Joseph et al. Annals of Intensive Care
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- IL-6 and other biomarkers as predictors of severity in COVID-19
- (2020) N Broman et al. ANNALS OF MEDICINE
- Cytokine Storm
- (2020) David C. Fajgenbaum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics
- (2020) Caio P. Gomes et al. Frontiers in Cellular and Infection Microbiology
- Post covid 19 pulmonary fibrosis. Is it real threat?
- (2020) Deependra Kumar Rai et al. Indian Journal of Tuberculosis
- NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity
- (2019) Keywan Mortezaee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targets for improving tumor response to radiotherapy
- (2019) Keywan Mortezaee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Stromal reprogramming: A target for tumor therapy
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review
- (2018) Keywan Mortezaee CELL BIOCHEMISTRY AND FUNCTION
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
- (2018) Margherita Norelli et al. NATURE MEDICINE
- Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches
- (2018) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
- (2018) Landon Browning et al. Cancer Management and Research
- Obesity-Induced TNFα and IL-6 Signaling: The Missing Link between Obesity and Inflammation—Driven Liver and Colorectal Cancers
- (2018) Lara Kern et al. Cancers
- NADPH oxidase as a target for modulation of radiation response; implications to carcinogenesis and radiotherapy
- (2018) Keywan Mortezaee et al. Current Molecular Pharmacology
- Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-β1 signaling pathway
- (2016) Jia-Hong Wang et al. LABORATORY INVESTIGATION
- IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age
- (2015) Hirotake Tsukamoto et al. Nature Communications
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search